Producing antibodies
Pro Research Analysisby 
Searched over 200M research papers for "producing antibodies"
Antibody Production: Mechanisms and Advances
Histochemical Demonstration of Antibodies in Cells
A method for the specific histochemical demonstration of antibodies in cells involves a two-stage immunological reaction on frozen tissue sections. This process includes the reaction between tissue antibodies and a dilute antigen applied in vitro, followed by the detection of antigen absorption areas using a fluorescein-labelled antibody. This technique reveals the presence of antibodies in plasma cells within various tissues, such as the spleen, lymph nodes, ileum, and liver, particularly after a series of antigen injections .
Generation and Maintenance of Plasma Cells
The production of antibodies is intricately linked to the generation and maintenance of plasmablasts and plasma cells from B cell precursors. Plasmablasts are short-lived cells that mediate the early antibody response, while plasma cells are long-lived and sustain humoral immunity. The differentiation of B cells into these antibody-secreting cells is governed by a complex gene-regulatory network influenced by environmental stimuli .
Large-Scale Production of Monoclonal Antibodies
The clinical and commercial success of monoclonal antibodies has driven the need for large-scale production in mammalian cell cultures. Advances in expression technology and process optimization, particularly the development of fed-batch cultures, have significantly improved the productivity of cell cultures. This has led to a 100-fold increase in productivity over the past 15 years, reducing manufacturing costs and development times for clinical testing .
Rapid Generation of Human Monoclonal Antibodies
A novel protocol for producing antigen-specific human monoclonal antibodies (hmAbs) involves isolating antibody-secreting cells (ASCs) from blood collected shortly after vaccination. These cells are sorted, and their antibody genes are amplified, cloned, and transfected into human cell lines. This method can rapidly generate numerous antigen-specific hmAbs within 28 days, offering a more efficient alternative to traditional methods like B-cell immortalization or phage display .
Antibody Production in Response to Antigenic Stimuli
Following an antigenic stimulus, antibodies are first detectable in the cytoplasm and sometimes in the nucleus of large, immature cells in the lymph nodes. These cells, which are hematogenous stem cells, multiply and differentiate into mature plasma cells containing antibodies. The primary immune response generates fewer antibody-containing cells compared to the secondary response, which produces hundreds of such cells in the same area .
Role of Lymphatic Glands and Granulomas in Antibody Production
After subcutaneous injection of antigens, antibody production occurs in regional lymphatic glands and the granulation tissue surrounding the injection site. The regional lymphatic glands show maximum antibody-containing cells two weeks post-injection, while local granulomas exhibit antibody production from 14 days onwards, lasting up to seven weeks. The adjuvant effect of aluminum phosphate prolongs antigen absorption, enhancing the stimulation of antibody-producing cells .
Clonal Selection and Learning in the Antibody System
Antibody-producing B cells undergo a selection process involving gene rearrangements and somatic hypermutation. This process generates a diverse antibody repertoire, with only high-affinity mutants surviving to become memory cells. Autoreactive cells are counter-selected at both stages, ensuring the specificity and effectiveness of the immune response .
In Vitro Production of Human Antibodies Using Bacteriophage
An in vitro method for producing human antibodies involves antigen-driven selection using bacteriophage display of antibody fragments. This technique allows the generation of high-affinity, specific human antibody fragments without the need for immunization, providing a valuable tool for antibody production .
Conclusion
The production of antibodies involves complex processes at both cellular and molecular levels, from the initial antigenic stimulus to the generation of long-lived plasma cells. Advances in large-scale production techniques and rapid generation protocols have significantly improved the efficiency and speed of producing monoclonal antibodies. These developments hold promise for enhancing therapeutic applications and understanding immune responses.
Sources and full results
Most relevant research papers on this topic